| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $402.8M | +26.9% |
| Cost of Revenue | $204.0M | +25.0% |
| Gross Profit | $198.8M | +28.9% |
| R&D Expense | $8.8M | +39.7% |
| SG&A Expense | $112.3M | +36.7% |
| Operating Income | $87.6M | +26.1% |
| Interest Expense | $52.1M | -22.3% |
| Pre-tax Income | $29.1M | +1092.5% |
| Income Tax | $6.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.1M | +151.6% |
| Accounts Receivable | $63.8M | +8.2% |
| Inventory | $92.6M | +18.8% |
| Current Assets | $220.7M | +29.3% |
| Total Assets | $1.45B | +38.1% |
| Current Liabilities | $41.8M | -18.8% |
| Long-term Debt | $277.3M | -48.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.0M | +329.0% |
| Investing Cash Flow | -$392.1M | -440.4% |
| Financing Cash Flow | $370.0M | +709.4% |
| -3.1% |
| Net Income | $22.2M | +581.7% |
| EPS (Basic) | $0.25 | +100.0% |
| EPS (Diluted) | $0.24 | +100.0% |
| Total Liabilities |
| $362.1M |
| -42.7% |
| Stockholders' Equity | $1.09B | +160.3% |